Showing results (681-690 of 725) with videos related to
Sort By:
Pageof 73
Journal of Translational Medicine|October 18, 2023
Genetic assessment of pathogenic germline alterations in lysosomal genes among Asian patients with pancreatic ductal adenocarcinomaYoungil Koh, Hyemin Kim, So Young Joo, et al.Journal of Cancer|January 6, 2023
Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinomaMi Jeong Hong, Ji Eun Park, Shin Yup Lee, et al.Journal of Cachexia, Sarcopenia and Muscle|November 23, 2024
Skeletal Muscle Index Changes on Locoregional Treatment Application After FOLFIRINOX and Survival in Pancreatic CancerJi Hye Min, Jeong Il Yu, Seong Hyun Kim, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in asian countries: a study by the Asian Network for Surveillance of Resistant PathogensJae-Hoon Song, Sook-In Jung, Hyun Kyun Ki, et al.Nature Communications|December 14, 2018
Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acneChristos Petridis, Alexander A Navarini, Nick Dand, et al.Nature Ecology & Evolution|February 27, 2019
Antarctic blackfin icefish genome reveals adaptations to extreme environmentsBo-Mi Kim, Angel Amores, Seunghyun Kang, et al.Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 23, 2015
Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter studyTae Hyeon Kim, Tae Jun Song, Jin-Hyeok Hwang, et al.Thoracic Cancer|October 14, 2022
Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non-small cell lung cancerSun Ha Choi, Sook Kyung Do, Shin Yup Lee, et al.British Journal of Cancer|October 31, 2023
Efficacy of GV1001 with gemcitabine/capecitabine in previously untreated patients with advanced pancreatic ductal adenocarcinoma having high serum eotaxin levels (KG4/2015): an open-label, randomised, Phase 3 trialJung Hyun Jo, Yong-Tae Kim, Ho Soon Choi, et al.Plos One|December 14, 2017
Risk factors associated with adverse events during endoscopic ultrasound-guided tissue samplingKwang Hyuck Lee, Eun Young Kim, Juhee Cho, et al.Pageof 73